The global analgesic infusion pumps market is anticipated to witness growth over the forecast period. Increasing demand for analgesic drug treatments for pain management in chronic conditions such as complex pain syndrome, myocardial infarction, failed back syndrome and post-operative pain is the high impact rendering driver for the growth of market. Analgesic infusion pumps are used to treat some neurological conditions such as spinal cord injury and cerebral palsy. These pumps implanted inside the body or can be used externally. Increasing burden on hospitals owing to growing hospital admissions is one of the major concerns for healthcare facilities. Various initiatives have been taken by government which includes encouraging home healthcare therapies to reduce hospital stays. Increasing awareness pertaining to advantages associated with these pumps such as it provides the constant delivery of analgesic during parturition, it decreases the variability of local anesthetics in maternal and fetal blood and it is the safe method which utilizes time more efficiently. Dose administration is difficult for geriatric population which is acting as a restraining factor for the growth of this market.
The global analgesic infusion pumps market is broadly segmented on the basis product and application. Ambulatory analgesia infusion pumps, volumetric analgesia infusion pumps, and syringe analgesia infusion pumps are the product segments of this market. On the basis of application, analgesic infusion pumps market is divided into accidents and trauma, post surgical application, cancer patients, labor pain, and others. Ambulatory analgesic pumps market is expect to show a significant growth rate during the forecast period owing to increasing need for these pumps.
North America, Europe, Asia Pacific, and RoW are the major regions analyzed in this study. North America held the largest share of analgesic infusion pumps market followed Europe. The presence of well-developed healthcare infrastructure and the introduction of technologically advanced products coupled with increasing adoption rates are some drivers attributing to its large share. Asia Pacific market is expected to show fruitful CAGR during the forecast period owing to the rapidly developing healthcare infrastructure, growing government initiatives and increasing awareness regarding the use of infusion pumps.
The key market participants for the global analgesic infusion pumps market are B. Braun Melsungen AG, Animas Corporation, Baxter International Inc., Fresenius Kabi AG, Medtronic Inc., KD Scientific, Inc., CareFusion Corporation, Hospira, Inc., Terumo Corporation and Smiths Medical.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.